Don’t assume that Warren Buffett has stepped back from his role now that he no longer holds the position of Berkshire Hathaway‘s (BRKA 0.16%) (BRKB 0.11%) CEO. He affirmed in a recent CNBC interview with Becky Quick that he still reports to the office every day and is deeply engaged in Berkshire’s investment strategies.
This year, several of Buffett’s earlier investments are showing remarkable performance. Like Buffett, these investments may not be flashy, but they are reliable. Here are his top three stocks for 2026.
1. Mitsubishi
Mitsubishi (MSBHF 1.32%) has emerged as Buffett’s largest winner year-to-date, with its shares soaring approximately 45%. Although Buffett has typically steered clear of international stocks, he made an exception for five stocks in Japan a few years back, with Mitsubishi now being Berkshire’s seventh largest holding.
Mitsubishi stands as the most prominent and arguably the strongest of Japan’s trading houses. Its diverse operations span chemicals, energy, food, finance, machinery, and metals. Earlier this year, Mitsubishi’s acquisition of Aethon allowed it entry into the U.S. shale gas market. The increasing demand for liquid natural gas (LNG), copper, and other materials has positively impacted Mitsubishi, while extensive stock buybacks have also uplifted earnings per share.
2. Marubeni
The five trading houses in Berkshire’s portfolio display similar business models, leading to often correlated stock movements. Therefore, it’s no surprise that Marubeni (MARUF +1.83%) (MARUY 0.69%) is also one of Buffett’s top-performing stocks this year. Marubeni’s shares have skyrocketed over 350% in the past five years, significantly outpacing its peers.
Marubeni’s operations encompass multiple sectors like aerospace, agriculture, chemicals, energy, and real estate. The company has also pursued aggressive share repurchases and consistently raised its dividends. These shareholder rewards contributed to Buffett’s characterization of Marubeni in 2023 as one of the few stocks he expects Berkshire to “maintain indefinitely.”
3. DaVita
Instead of another Japanese stock, the third spot among Buffett’s best performers is held by U.S. dialysis services company DaVita (DVA 0.15%), which has experienced around a 30% surge year-to-date. DaVita exceeded revenue and earnings forecasts in its fourth-quarter results revealed in February 2026, and provided an optimistic outlook for the full year.
This healthcare stock exemplifies the type of investment Buffett prefers. It offers essential services, reliable recurring revenue, and cash flow. Additionally, DaVita has implemented significant stock buybacks and has diversified beyond solely dialysis services through strategic investments in companies like Elara Caring.
Should You Invest in These Buffett Stocks?
Are these high-performing Buffett stocks worth investing in? It’s important not to chase momentum recklessly. Notably, Berkshire hasn’t recently acquired any of these three stocks, having even slightly reduced its position in DaVita earlier this year. Nonetheless, these stocks may pique the interest of many investors.
Value investors might find DaVita attractive, especially since it trades at only 10.7 times forward earnings despite its solid gains in 2026. Meanwhile, income-focused investors may lean towards the two Japanese stocks, which offer modest dividend yields—2.1% for Mitsubishi and 1.8% for Marubeni—but both possess stable, diversified businesses that indicate potential for dividend growth in the future.
